AGM briefly adjourned after protesters wearing T-shirts labelled ‘No more big oil’ burst into song The chair of NatWest was forced to defend the bank against accusations of “climate backtracking” at a ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Khadija Khartit is a strategy, investment, and funding expert, and ...
Wondering where to stream 'The Maze Runner' without the hassle? Here are platforms and services with rental, purchase, and subscription options, so you can start watching sooner. In the US, you can ...
How machine intelligence changes the rules of business by Marco Iansiti and Karim R. Lakhani In 2019, just five years after the Ant Financial Services Group was launched, the number of consumers using ...
Michael Schmidt, CFA, is a staff member of FINRA's Dispute Resolution Board with 20+ years of experience in the financial market. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results